SHL TELEMEDICINE LTD. Press release
A law suit and a request for an interim injunction was filed by shareholders against SHL Telemedicine Ltd. regarding the appointment of an external director
Tel Aviv / Zurich, 13 January 2017 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, today announced that on 12 January 2017 a group of shareholders of the Company, represented by Yariv Alroy, has filed a law suit against SHL, Ronen Harel (its external director), Cai Mengke, and Himalaya Asset Management Limited (Himalaya) asking the Tel Aviv district court to declare that Cai Mengke and Himalaya are controlling shareholders of SHL acting in concert, that the decision to appoint Ronen Harel as an external director at the Special General Meeting of January 5, 2017 was against the governing laws of Israel and thus void, to instruct SHL to reconvene a Special General Meeting and instruct SHL to count Cai Menkge and Himalaya's vote as controlling shareholders under the laws of Israel.
As part of the law suit a request for an interim injunction with respect to the resolution of the Special General Meeting to appoint Ronen Harel as external director was also filed by said shareholders. The request for interim injunction is against SHL and Ronen Harel. The court has not granted the injunction ex parte, i.e., the court has granted the right to be heard to the respondents. Respondents have seven days to submit their response and the parties are summoned for 24 January 2017.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information, please visit the web site at www.shl-telemedicine.com.
For further information, please contact:
Martin Meier-Pfister, IRF Communications, phone: +41 43 244 81 40, shl@irfcom.ch
Ehud Ben-Yair, CFO, ehudb@shl-telemedicine.com
| Provider | Channel | Contact | ||
|---|---|---|---|---|
|
Tensid EQS Ltd., Switzerland www.tensid.ch |
newsbox.ch www.newsbox.ch |
Provider/Channel related enquiries marco@tensid.ch +41 41 763 00 50 |
